Where appropriate, further investigations, including a young stroke blood panel, should be performed to evaluate for conditions such as antiphospholipid syndrome, JAK2 mutation, or paroxysmal nocturnal hemoglobinuria. This evidence concerns the gene JAK2 and paroxysmal nocturnal hemoglobinuria.